Pharmacoepidemiology MDPI

Aims Pharmacoepidemiology (ISSN 2813-0618) is an international, peer-reviewed, open access journal that publishes original articles, critical reviews, and short communications on high-quality studies across the fields of pharmacoepidemiology, clinical pharmacology, and epidemiology. The aim of Pharmacoepidemiology is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, the journal has no restriction on the maximum length of the papers. Full experimental details should be provided so that the results can be reproduced. Scope Pharmacoepidemiology welcomes manuscripts covering a broad range of areas including, but not limited to: designs, analyses, results, and interpretations of studies on drugs, biologics, or medical devices; molecular pharmacoepidemiology; the methodology of pharmacoepidemiology; pharmacovigilance; patient safety; patterns of drug utilization; post-marketing surveillance; pharmacoeconomics; the formulation and interpretation of regulatory guidelines; studies on the benefits/safety/effectiveness of pharmaceuticals, biologics, or medical devices; harm/benefit assessments in drug therapy; the evaluation of risk management plans on pharmaceuticals, biologics and medical devices.